Observation Versus Treatment in Men with Prostate Cancer

Peter Yu, MD, director, Palo Alto Medical Foundation, president-elect, ASCO, discusses results of a review that examined men's treatment decisions after seeing a rise in their PSA levels.

Peter Yu, MD, director, Palo Alto Medical Foundation, president-elect, ASCO, discusses results of a review that examined men’s treatment decisions after seeing a rise in their PSA levels.

Related Content:

InterviewsSpecialty PharmacyOncology
FDA Grants Accelerated Approval to Enhertu for HER2 Mutant Non-small Cell Lung Cancer
Efficacy of Neoadjuvant Immunotherapy on Breast Cancer is Independent of Race
US Representatives Push Congress to Pass Legislation to Digitalize Prescribing Information for Patients, Pharmacists